Related Experiment Video
Updated: Feb 21, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Indole-3-propionic Acid Is an Endogenous Agonist of TAS2R38
Yeeun Park1, Jin Yoo2, Na Young Kim3
1Department of Food Science and Biotechnology, Ewha Womans University, Seoul 03760, Republic of Korea.
Abstract:
Bitter taste receptor 38 (TAS2R38) is increasingly recognized for its extra-oral roles in metabolic and immune regulation but remains incompletely understood due to limited endogenous ligands. Therefore, we aimed to discover a novel TAS2R38 agonist from food- and microbiota-derived metabolites of aromatic amino acids. Using AI-based molecular modeling, a promising ligand-binding pocket and key interactions for TAS2R38 activation, including π-π stacking via aromatic rings and hydrogen bonding via polar head groups, were characterized. Guided by these features, indole-3-propionic acid (IPA)─a gut microbiota-derived tryptophan metabolite─was identified and validated by cell-based assays as a potent TAS2R38 agonist. IPA significantly suppressed forskolin-induced intracellular cAMP accumulation in TAS2R38-expressing HEK293T cells (IC50 = 1.06 μM), comparable to that of the well-known strong agonist phenylthiocarbamide (PTC). Structure-activity analyses of IPA analogs further validated the proposed binding mechanism. This study provides a new molecular framework for designing functional food ingredients targeting extra-oral TAS2Rs.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:39Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
IP3/DAG Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
G-protein Coupled Receptors